12/10/25 16:42 | 12/8/25 | FULC | Fulcrum Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | T | | S | -58,377 | 13.98 | 0 | -4,175 | -41 | 6,054 | I | | | | | | | | | | | | | | |
11/24/25 17:43 | 11/20/25 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | | S.m | -1,201 | 39.61 | 0 | -30 | -16 | 159 | I | | | | | | | | | | | | | | |
11/19/25 20:43 | 11/17/25 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | | S.m | -5,500 | 40.34 | 0 | -136 | -45 | 168 | I | | | | | | | | | | | | | | |
10/30/25 18:40 | 10/28/25 | VOR | Vor Biopharma Inc. | | Health | BioPrd | Biological Products, (No Diag | Ra Capital Management, L.P. | MA | DT | | S.m | -10,369 | 25.90 | 0 | -400 | -34 | 780 | I | | | | | | | | | | | | | | |
10/28/25 21:05 | 10/24/25 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | | S.m | -14,763 | 39.51 | 0 | -374 | -64 | 209 | I | | | | | | | | | | | | | | |
10/27/25 20:04 | 10/23/25 | VOR | Vor Biopharma Inc. | | Health | BioPrd | Biological Products, (No Diag | Ra Capital Management, L.P. | MA | DT | | S.m | -6,205 | 28.06 | 0 | -221 | -16 | 1,180 | I | | | | | | | | | | | | | | |
10/22/25 19:48 | 10/20/25 | VOR | Vor Biopharma Inc. | | Health | BioPrd | Biological Products, (No Diag | Ra Capital Management, L.P. | MA | DT | | S.m | -3,434 | 29.34 | 0 | -117 | -8 | 1,401 | I | | | | | | | | | | | | | | |
10/17/25 18:03 | 10/15/25 | VOR | Vor Biopharma Inc. | | Health | BioPrd | Biological Products, (No Diag | Ra Capital Management, L.P. | MA | DT | | S.m | -13,707 | 29.54 | 0 | -464 | -97 | 15 | I | | | | | | | | | | | | | | |
8/13/24 17:03 | 8/9/24 | ANTX | An2 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | T | | S | -3,807 | 1.08 | 0 | -3,525 | -92 | 301 | I | | | | | | | | | | | | | | |